Wang, X.; Yung, M.M.H.; Sharma, R.; Chen, F.; Poon, Y.-T.; Lam, W.-Y.; Li, B.; Ngan, H.Y.S.; Chan, K.K.L.; Chan, D.W.
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis. Cancers 2021, 13, 4795.
https://doi.org/10.3390/cancers13194795
AMA Style
Wang X, Yung MMH, Sharma R, Chen F, Poon Y-T, Lam W-Y, Li B, Ngan HYS, Chan KKL, Chan DW.
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis. Cancers. 2021; 13(19):4795.
https://doi.org/10.3390/cancers13194795
Chicago/Turabian Style
Wang, Xueyu, Mingo M. H. Yung, Rakesh Sharma, Fushun Chen, Ying-Tung Poon, Wai-Yip Lam, Benjamin Li, Hextan Y. S. Ngan, Karen K. L. Chan, and David W. Chan.
2021. "Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis" Cancers 13, no. 19: 4795.
https://doi.org/10.3390/cancers13194795
APA Style
Wang, X., Yung, M. M. H., Sharma, R., Chen, F., Poon, Y. -T., Lam, W. -Y., Li, B., Ngan, H. Y. S., Chan, K. K. L., & Chan, D. W.
(2021). Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis. Cancers, 13(19), 4795.
https://doi.org/10.3390/cancers13194795